Ryerson Holding Corporation stock analysis: expert insights on fundamentals, industry trends, and stock forecast for informed investing.
Key Takeaways
- Ryerson Holding Corporation has a low Quality Score of 19/100, reflecting its negative earnings (-$1.48 EPS) and weak returns on equity (-4.2%) and assets (0.0%).
- The company shows moderate Growth potential with a 5-year revenue decline of -10.2% but a recent strong revenue growth of 37.9% TTM, supported by a 58/100 Growth Score.
- The Opportunity Score of 29/100 signals limited entry advantage currently, as the stock trades near its 2-year high ($27.53 vs. $30.41) despite negative free cash flow (-$512M) and negative FCF yield (-35.9%).
Ryerson Holding Corporation has staged an impressive revenue rebound, but the fundamentals still leave investors with a difficult trade-off: improving top-line momentum versus weak profitability, negative earnings, and heavy free cash flow burn. This Ryerson Holding Corporation stock analysis finds a company that looks inexpensive on some sales-based measures, yet financially stretched when viewed through cash flow, margins, and return metrics.
What Is Happening With the Stock Price
Ryerson trades at $27.53, well above its two-year low of $17.69 and below its two-year high of $30.41. Based on its position within that two-year range, the stock sits in the upper end of its recent trading band. That suggests market sentiment has improved meaningfully from the lows, even though the company’s underlying profitability remains under pressure.
With a market capitalization of $1.43 billion, Ryerson is not being valued as a high-quality compounder. The stock’s price-to-book ratio of 1.11 indicates investors are paying only a modest premium to book value. However, that restraint may be justified given the company’s negative EPS of -$1.48 and the absence of a meaningful P/E ratio.
Quality: Is This a Financially Sound Business?
Quality is the biggest concern. Ryerson’s proprietary Quality Score is just 19 out of 100, reflecting weak profitability, poor capital efficiency, and negative cash generation. The company’s gross margin of 17.3% shows that it still earns a spread on its products, but much of that is absorbed before reaching the bottom line. Operating margin is only 2.1%, and net profit margin is negative at -0.9%.
That thin margin structure matters. A business with low operating margins has less room for error if revenue softens, costs rise, or pricing becomes less favorable. Ryerson’s return on assets is 0.0%, while return on equity is -4.2%, indicating that the company is not currently generating attractive returns on the capital deployed in the business.
Cash flow is even more troubling. Free cash flow over the trailing twelve months was -$512 million, producing a deeply negative free cash flow yield of -35.9%. That is a major red flag, especially because earnings are already negative. In this Ryerson Holding Corporation stock analysis, the gap between reported revenue momentum and free cash flow weakness is one of the most important issues for investors to monitor.
The balance sheet is mixed. A current ratio of 2.21 suggests Ryerson has adequate short-term liquidity on a broad basis, but the quick ratio of 0.93 is less comfortable because it excludes inventory. Debt-to-equity of 1.02 points to meaningful leverage, though not extreme. The dividend yield of 2.8% may appeal to income investors, but the payout ratio of 118.7% looks stretched, particularly alongside negative EPS and negative free cash flow.
Growth: Does This Company Have Real Upside?
Ryerson’s growth profile is more complicated than the headline numbers suggest. Revenue over the trailing twelve months was $5.0 billion, and TTM revenue growth was a strong 37.9%. That is the clearest bullish data point in the set and helps explain why the stock has moved toward the upper end of its two-year range.
However, the longer-term trend is much less encouraging. Revenue growth over the past five years, measured by CAGR, is -10.2%. That contrast is unusual and worth flagging. It may suggest a sharp cyclical rebound, a recovery from a depressed base, changes in pricing, volume normalization, or other industry-specific factors. What it does not yet prove is durable multi-year growth.
The lack of earnings growth data, combined with negative EPS, limits confidence in the growth story. Revenue expansion is useful only if it eventually translates into stronger margins, earnings, and cash generation. At present, Ryerson’s 2.1% operating margin and negative net margin show that the business has not yet converted its sales rebound into robust profitability.
Valuation also sends mixed signals. EV/revenue of 0.54 appears low, which can make the stock look inexpensive relative to its $5.0 billion revenue base. But EV/EBITDA of 31.54 is high, likely reflecting weak EBITDA relative to enterprise value. In other words, sales are plentiful, but profits and cash flow are not.
Opportunity: Is Now a Good Time to Enter?
The Opportunity Score of 29 out of 100 suggests the setup is not especially attractive for new buyers. The stock is already in the upper end of its two-year range, so investors are not getting a clearly distressed entry point. At the same time, the absence of a P/E ratio removes one of the most common valuation anchors because earnings are negative.
There is a possible contrarian case: price-to-book is only 1.11, EV/revenue is 0.54, and TTM revenue growth is strong. If margins improve and free cash flow normalizes, the stock could look more compelling. But that is a turnaround argument, not a high-quality earnings story today.
Ryerson Holding Corporation Stock Analysis: The Bottom Line
This Ryerson Holding Corporation stock analysis points to a cautious verdict. Ryerson has real revenue momentum, and the stock is not expensive on price-to-book or EV/revenue. But negative EPS, weak margins, negative ROE, substantial free cash flow burn, and a stretched payout ratio outweigh those positives for now.
The proprietary scores tell the same story: Quality at 19/100, Growth at 58/100, and Opportunity at 29/100. Growth is the bright spot, but it is not enough to offset weak financial health and an unattractive entry setup. With an overall signal of Sell, Ryerson looks better suited for watchlists than new capital until profitability and cash flow show clear improvement.
Financial Metrics Summary
| Metric | Value |
|---|---|
| Price & Valuation | |
| Current Price | $27.53 |
| 2-Year Low | $17.69 |
| 2-Year High | $30.41 |
| Market Cap | $1.43B |
| EV / Revenue | 0.54 |
| Our Scores | |
| Quality Score | 19 / 100 |
| Growth Score | 58 / 100 |
| Opportunity Score | 29 / 100 |
| Profitability | |
| Earnings Per Share | -$1.48 |
| Return on Assets | 0.0% |
| Return on Equity | -4.2% |
| Net Profit Margin | -0.9% |
| Gross Margin | 17.3% |
| Operating Margin | 2.1% |
| Growth | |
| Revenue Growth (5Y CAGR) | -10.2% |
| Revenue Growth (TTM) | 37.9% |
| Balance Sheet | |
| Debt-to-Equity | 1.02 |
| Current Ratio | 2.21 |
| Quick Ratio | 0.93 |
| Income & Dividends | |
| Dividend Yield | 2.8% |
| Payout Ratio | 118.7% |
Data as of June 24, 2026
Our Three-Pillar Assessment
| Quality |
19/100 |
| Growth |
58/100 |
| Opportunity |
29/100 |
Quality measures business fundamentals: profitability, cash flow discipline, and balance sheet strength.
Growth captures revenue momentum, gross margin scalability, and the Rule of 40 efficiency test.
Opportunity signals entry timing: current valuation versus history and price position in the 2-year range.
Current price: $27.53 trading 9% below from its 2-year high of $30.41.
This analysis is done using financial data from Yahoo Finance.
Always conduct your own due diligence and consult a qualified financial advisor before making investment decisions.